Resource

 

 

 

 

 

 

 

 

 

 

 

MSD enters into an agreement to acquire Viralytics for AUD $502 million

01 Mar 2018

Baker McKenzie acts for client Merck & Co., Inc. (known as MSD outside the United States and Canada), one of the largest pharmaceutical companies in the world, on its entry into a definitive agreement under which it is proposed that MSD (through a subsidiary) will acquire Viralytics Limited (Viralytics) by way of a scheme of arrangement for AUD 1.75 per share (representing a total value of approximately AUD 502 million).

PARTNER MOVES - Mayer Brown's private equity expansion in London continues with addition of Neil Evans as partner

01 Mar 2018

Mayer Brown is pleased to announce that Neil Evans has been appointed as a partner in the firm's private equity team in London.

Neil represents private equity sponsors and corporates on public and private M&A, ECM, buyout transactions and equity investments across a broad range of sectors. Neil joins Mayer Brown from Simpson Thacher & Bartlett. Earlier in his career he worked at Clifford Chance, where he also trained.

PARTNER MOVES - Government & Internal Investigations Attorney Richard Sharpe Joins Hong Kong Office of Kirkland & Ellis

01 Mar 2018

Kirkland & Ellis is pleased to announce that Richard Sharpe has joined the Firm’s Hong Kong office as a partner in the Government and Internal Investigations Group.

Mr. Sharpe, dually qualified as a Hong Kong solicitor and a U.K. barrister, focuses on assisting multinational clients with a variety of white-collar and international risk matters, including anti-bribery and corruption, anti-money laundering, international sanctions, cyber-crime, and other cross-border investigations.

Greenberg Traurig Attorneys Represent INSIGHTEC in Historic Financing Transaction

01 Mar 2018

Greenberg Traurig, LLP Shareholder Robert L. Grossman led a team of firm attorneys as U.S. counsel representing INSIGHTEC in obtaining $150 million in Series E financing in what is thought to be the largest private, pre-IPO med-tech funding round in Israel’s history. Haifa, Israel-based INSIGHTEC, led by Miami-based Dr. Maurice Ferré, is a commercial-stage medical device company revolutionizing surgery with MRI-guided focused ultrasound.

Davis Polk Advises Comcast on Its £22.1 Billion Possible Cash Offer for Sky

01 Mar 2018

Davis Polk is advising Comcast Corporation in connection with its £22.1 billion ($30.8 billion) possible cash offer to acquire the entire share capital of Sky plc. Under the terms of Comcast’s proposal, Sky shareholders would receive £12.50 in cash for each share. If made, the offer, that would be implemented as a tender offer with a 50% plus one share acceptance condition, would be subject to regulatory and antitrust approvals and other customary conditions.

Withers represents Royal Free Charity on launch of Pears Building clinical research centre development

01 Mar 2018

Withers has advised the Royal Free Charity, the charitable foundation for the Royal Free London NHS Foundation Trust, on an agreement with contractor Willmott Dixon which commences the development of the Pears Building, a cutting-edge institute for clinical research on immunity and transplantation.